The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montoya, M.
Right arrow Articles by Del Val, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montoya, M.
Right arrow Articles by Del Val, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1999, 163: 1914-1922.
Copyright © 1999 by The American Association of Immunologists

Intracellular Rate-Limiting Steps in MHC Class I Antigen Processing1

María Montoya2 and Margarita Del Val3

Centro Nacional de Biología Fundamental, Instituto de Salud Carlos III, Madrid, Spain

Quantitative aspects of the endogenous pathway of Ag processing and presentation by MHC class I molecules to CD8+ CTL were analyzed over a wide range of Ag expression in recombinant vaccinia virus-infected cells expressing ß-galactosidase as model Ag. Only the amount of starting Ag was varied, leaving other factors unaltered. Below a certain level of Ag synthesis, increasing protein amounts led to a sharp rise in recognition by CTL. Higher levels of Ag expression led to a saturation point, which intracellularly limited the number of naturally processed peptides bound to MHC and thereby also CTL recognition. The rate-limiting step was located at the binding of the antigenic peptide to MHC inside the vaccinia virus-infected cell or before this event.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Bulik, B. Peters, and H.-G. Holzhutter
Quantifying the Contribution of Defective Ribosomal Products to Antigen Production: A Model-Based Computational Analysis
J. Immunol., December 15, 2005; 175(12): 7957 - 7964.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Palliser, E. Guillen, M. Ju, and H. N. Eisen
Multiple Intracellular Routes in the Cross-Presentation of a Soluble Protein by Murine Dendritic Cells
J. Immunol., February 15, 2005; 174(4): 1879 - 1887.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Samino, D. Lopez, S. Guil, P. de Leon, and M. Del Val
An Endogenous HIV Envelope-derived Peptide without the Terminal NH3+ Group Anchor Is Physiologically Presented by Major Histocompatibility Complex Class I Molecules
J. Biol. Chem., January 9, 2004; 279(2): 1151 - 1160.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Fruci, G. Lauvau, L. Saveanu, M. Amicosante, R. H. Butler, A. Polack, F. Ginhoux, F. Lemonnier, H. Firat, and P. M. van Endert
Quantifying Recruitment of Cytosolic Peptides for HLA Class I Presentation: Impact of TAP Transport
J. Immunol., March 15, 2003; 170(6): 2977 - 2984.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. N. Mueller, C. M. Jones, W. Chen, Y. Kawaoka, M. R. Castrucci, W. R. Heath, and F. R. Carbone
The Early Expression of Glycoprotein B from Herpes Simplex Virus Can Be Detected by Antigen-Specific CD8+ T Cells
J. Virol., February 15, 2003; 77(4): 2445 - 2451.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Lopez, B. C. Gil-Torregrosa, C. Bergmann, and M. Del Val
Sequential Cleavage by Metallopeptidases and Proteasomes Is Involved in Processing HIV-1 ENV Epitope for Endogenous MHC Class I Antigen Presentation
J. Immunol., May 15, 2000; 164(10): 5070 - 5077.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. C. Ramírez, M. M. Gherardi, and M. Esteban
Biology of Attenuated Modified Vaccinia Virus Ankara Recombinant Vector in Mice: Virus Fate and Activation of B- and T-Cell Immune Responses in Comparison with the Western Reserve Strain and Advantages as a Vaccine
J. Virol., January 1, 2000; 74(2): 923 - 933.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.